Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2774 | 2623 | 46.2 | 72% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2496 | 2155 | METHAMPHETAMINE//MOL NEUROPSYCHIAT SECT//MOL NEUROPSYCHIAT BRANCH |
25092 | 243 | SURG SCI ANESTHESIOL INTENS CARE MED//H 290 51//SURG SCI ANAESTHESIOL INTENS CARE MED |
25771 | 225 | CEREBROLYSIN//CEREBROLYSIN R//QEEG SLOWING |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | METHAMPHETAMINE | Author keyword | 444 | 34% | 41% | 1084 |
2 | CEREBROLYSIN | Author keyword | 129 | 74% | 4% | 96 |
3 | SURG SCI ANESTHESIOL INTENS CARE MED | Address | 50 | 73% | 1% | 38 |
4 | MOL NEUROPSYCHIAT SECT | Address | 22 | 47% | 1% | 35 |
5 | H 290 51 | Author keyword | 15 | 71% | 0% | 12 |
6 | MOL NEUROPSYCHIAT BRANCH | Address | 15 | 33% | 1% | 36 |
7 | SURG SCI ANAESTHESIOL INTENS CARE MED | Address | 14 | 59% | 1% | 16 |
8 | METHAMPHETAMINE ABUSE | Author keyword | 10 | 52% | 0% | 13 |
9 | BIOENVIRONM MED ANAT | Address | 9 | 83% | 0% | 5 |
10 | SYDNOCARB | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | METHAMPHETAMINE | 444 | 34% | 41% | 1084 | Search METHAMPHETAMINE | Search METHAMPHETAMINE |
2 | CEREBROLYSIN | 129 | 74% | 4% | 96 | Search CEREBROLYSIN | Search CEREBROLYSIN |
3 | H 290 51 | 15 | 71% | 0% | 12 | Search H+290+51 | Search H+290+51 |
4 | METHAMPHETAMINE ABUSE | 10 | 52% | 0% | 13 | Search METHAMPHETAMINE+ABUSE | Search METHAMPHETAMINE+ABUSE |
5 | SYDNOCARB | 9 | 83% | 0% | 5 | Search SYDNOCARB | Search SYDNOCARB |
6 | CEREBROLYSIN R | 8 | 100% | 0% | 5 | Search CEREBROLYSIN+R | Search CEREBROLYSIN+R |
7 | METABOLIC BRAIN ACTIVATION | 7 | 64% | 0% | 7 | Search METABOLIC+BRAIN+ACTIVATION | Search METABOLIC+BRAIN+ACTIVATION |
8 | PRENATAL DRUG | 6 | 71% | 0% | 5 | Search PRENATAL+DRUG | Search PRENATAL+DRUG |
9 | NANOWIRING | 6 | 100% | 0% | 4 | Search NANOWIRING | Search NANOWIRING |
10 | NEURONAL INJURIES | 6 | 100% | 0% | 4 | Search NEURONAL+INJURIES | Search NEURONAL+INJURIES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISMUTASE TRANSGENIC MICE | 108 | 73% | 3% | 82 |
2 | ABSTINENT METHAMPHETAMINE | 90 | 80% | 2% | 56 |
3 | ANTIOXIDANT COMPOUND H 290 51 | 67 | 87% | 1% | 33 |
4 | INDUCED DOPAMINERGIC NEUROTOXICITY | 47 | 55% | 2% | 60 |
5 | NORMOTENSIVE YOUNG RATS | 46 | 76% | 1% | 32 |
6 | SUBSTITUTED AMPHETAMINES | 39 | 48% | 2% | 60 |
7 | STRIATAL DOPAMINE | 34 | 16% | 8% | 199 |
8 | TERMINAL MARKERS | 34 | 93% | 0% | 13 |
9 | HIGH DOSE METHAMPHETAMINE | 32 | 85% | 1% | 17 |
10 | NOOTROPIC DRUG CEREBROLYSIN | 31 | 92% | 0% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Methamphetamine toxicity and messengers of death | 2009 | 161 | 332 | 76% |
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings | 2013 | 35 | 189 | 56% |
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine | 2014 | 14 | 157 | 45% |
New insights into the mechanism of action of amphetamines | 2007 | 239 | 90 | 46% |
A review of the clinical pharmacology of methamphetamine | 2009 | 129 | 147 | 59% |
Major physical and psychological harms of methamphetamine use | 2008 | 145 | 86 | 59% |
Neurocognitive effects of methamphetamine: A critical review and meta-analysis | 2007 | 168 | 170 | 55% |
The Methamphetamine Problem in the United States | 2010 | 76 | 68 | 62% |
An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans | 2013 | 17 | 108 | 66% |
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review | 2012 | 27 | 72 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SURG SCI ANESTHESIOL INTENS CARE MED | 50 | 73% | 1.4% | 38 |
2 | MOL NEUROPSYCHIAT SECT | 22 | 47% | 1.3% | 35 |
3 | MOL NEUROPSYCHIAT BRANCH | 15 | 33% | 1.4% | 36 |
4 | SURG SCI ANAESTHESIOL INTENS CARE MED | 14 | 59% | 0.6% | 16 |
5 | BIOENVIRONM MED ANAT | 9 | 83% | 0.2% | 5 |
6 | NORMAL PATHOL CLIN PHYSIOL | 9 | 22% | 1.4% | 36 |
7 | IECNSIR | 8 | 100% | 0.2% | 5 |
8 | INTEGRATED SUBST ABUSE PROGRAMS | 5 | 12% | 1.4% | 38 |
9 | SRHSA | 4 | 67% | 0.2% | 4 |
10 | NEUROFISIOL PLASTICIDAD SIN T | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000031638 | MDMA//ECSTASY//3 4 METHYLENEDIOXYMETHAMPHETAMINE |
2 | 0.0000025732 | COCAINE//NEONATAL ABSTINENCE SYNDROME//PRENATAL COCAINE |
3 | 0.0000016646 | DECRIMINALIZATION//DRUG POLICY//SPECIAL POPULAT |
4 | 0.0000015396 | NUCLEUS ACCUMBENS//COCAINE//DOPAMINE |
5 | 0.0000013390 | KHAT//CATHA EDULIS//CATHINONE |
6 | 0.0000010747 | ALPHA SYNUCLEIN//PARKIN//LRRK2 |
7 | 0.0000009917 | DELAY DISCOUNTING//IMPULSIVITY//PROBABILITY DISCOUNTING |
8 | 0.0000009708 | SIGMA RECEPTOR//SIGMA1 RECEPTOR//SIGMA RECEPTORS |
9 | 0.0000009602 | SUBSTANCE ABUSE//JOURNAL OF SUBSTANCE ABUSE TREATMENT//BUPRENORPHINE |
10 | 0.0000009044 | FENCAMFAMINE//N ACETYL ASPARTATE//N ACETYLASPARTATE |